FI943513A - 3-phenylureidoazepin-2-ones and benzazepin-2-ones useful as cholecystokinin antagonists - Google Patents

3-phenylureidoazepin-2-ones and benzazepin-2-ones useful as cholecystokinin antagonists Download PDF

Info

Publication number
FI943513A
FI943513A FI943513A FI943513A FI943513A FI 943513 A FI943513 A FI 943513A FI 943513 A FI943513 A FI 943513A FI 943513 A FI943513 A FI 943513A FI 943513 A FI943513 A FI 943513A
Authority
FI
Finland
Prior art keywords
ones
phenylureidoazepin
benzazepin
useful
cholecystokinin antagonists
Prior art date
Application number
FI943513A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI943513A0 (en
Inventor
Iii John A Lowe
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI943513A0 publication Critical patent/FI943513A0/en
Publication of FI943513A publication Critical patent/FI943513A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI943513A 1992-01-27 1994-07-26 3-phenylureidoazepin-2-ones and benzazepin-2-ones useful as cholecystokinin antagonists FI943513A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82567792A 1992-01-27 1992-01-27
PCT/US1992/010720 WO1993015059A1 (en) 1992-01-27 1992-12-16 3-phenylureido-azepin-2-ones and -benzazepin-2-ones useful as cholecystokinin antagonists

Publications (2)

Publication Number Publication Date
FI943513A0 FI943513A0 (en) 1994-07-26
FI943513A true FI943513A (en) 1994-07-26

Family

ID=25244657

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943513A FI943513A (en) 1992-01-27 1994-07-26 3-phenylureidoazepin-2-ones and benzazepin-2-ones useful as cholecystokinin antagonists

Country Status (19)

Country Link
EP (1) EP0625145A1 (en)
JP (1) JPH07503465A (en)
KR (1) KR950700257A (en)
CN (1) CN1074903A (en)
AU (1) AU3276193A (en)
BR (1) BR9207071A (en)
CA (1) CA2117367A1 (en)
CZ (1) CZ391092A3 (en)
FI (1) FI943513A (en)
HU (1) HUT70496A (en)
IL (1) IL104472A0 (en)
MX (1) MX9300409A (en)
NO (1) NO942775L (en)
NZ (1) NZ245759A (en)
RU (1) RU94038063A (en)
TW (1) TW213901B (en)
WO (1) WO1993015059A1 (en)
YU (1) YU4393A (en)
ZA (1) ZA93582B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2097688A1 (en) * 1993-07-14 1997-04-01 Pfizer Substituted hexahydroazepinones and tetrahydrobenzazepinones
US5618811A (en) * 1993-07-26 1997-04-08 Pfizer Inc. Tetrahydro-1H-benzazepinones and hexahydroazepinones as selective cholecystokinin-B receptor antagonists
EP0730581B1 (en) * 1993-11-22 2001-10-04 Merck & Co. Inc. 3-acylaminobenzazepines
US5453424A (en) * 1993-11-22 1995-09-26 Merck & Co., Inc. Furanodiazepines
JP3030091B2 (en) * 1994-10-04 2000-04-10 ファイザー・インコーポレーテッド Methods and intermediates for producing 3-amino-benzo [b] azepinone
DE69524623T2 (en) 1994-10-14 2002-08-08 Glaxo Wellcome Spa USE OF CCK-B RECEPTOR ANTAGONISTS FOR TREATING SLEEP DISORDERS
DE10153348A1 (en) 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituted benzo (b) azepin-2-one compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
US4767756A (en) * 1987-07-17 1988-08-30 E. R. Squibb & Sons, Inc. 3-substituted benzazepines
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck

Also Published As

Publication number Publication date
HUT70496A (en) 1995-10-30
NZ245759A (en) 1997-06-24
ZA93582B (en) 1994-07-27
JPH07503465A (en) 1995-04-13
IL104472A0 (en) 1993-05-13
MX9300409A (en) 1993-07-01
YU4393A (en) 1996-01-09
EP0625145A1 (en) 1994-11-23
WO1993015059A1 (en) 1993-08-05
FI943513A0 (en) 1994-07-26
NO942775L (en) 1994-09-20
NO942775D0 (en) 1994-07-26
BR9207071A (en) 1995-12-05
CZ391092A3 (en) 1994-01-19
AU3276193A (en) 1993-09-01
RU94038063A (en) 1996-05-27
KR950700257A (en) 1995-01-16
CN1074903A (en) 1993-08-04
TW213901B (en) 1993-10-01
HU9402195D0 (en) 1994-09-28
CA2117367A1 (en) 1993-08-05

Similar Documents

Publication Publication Date Title
FI931229A (en) SOM GLANSPIGMENT LAEMPADE BLANDNINGAR
FI934568A0 (en) HYDROFOBISITET SOM AOSTADKOMMITS MED METALLJONAKTIVERING
DE69400835T2 (en) Pollution preventing substance
FI931069A (en) KOLLOIDALT ROSTAT KAFFE SOM AROMATISERINGSPRODUKT
BR9304423A (en) Anchor
NO954767D0 (en) 4-amino-17 compounds such as C17-20-lyase and 5
FI943513A (en) 3-phenylureidoazepin-2-ones and benzazepin-2-ones useful as cholecystokinin antagonists
FI930722A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV POLYMERER SOM INNEHAOLLER AMMONIUMGRUPPER
FI923709A (en) I en saekerhetsskena laosbar vagn
FI934764A (en) Anordning som hindrar krympning av kabelisolering
DK0640187T4 (en) Anchorage
ATA151292A (en) FITTING
FI930219A (en) ANVAENDNING AV REAKTIONSBLANDNINGAR SOM GJUTBARA MASSOR
FI935826A0 (en) Kallsmoerjmedel med delvis neutraliserade phosphorsyraestrar som EP-tillsatsaemnen
ATA199692A (en) BOLT
DE9212519U1 (en) Seating
ATA151392A (en) FITTING
FI922527A (en) VAEGGKONSTRUKTION FOER ANORDNING I BYGGNADER
DK0707579T3 (en) Piperidinyl-substituted methanoanthracenes as D1 / D2 antagonists and 5 HT2-serotanin antagonists
FI554U1 (en) Reklam som aendrar faerg
FI922997A (en) TUGGUMMI SOM INNEHAOLLER VERKSAMMA AEMNEN
SE9301471D0 (en) NEW FORMULATION
SE9201297D0 (en) SYNERGISTIC COMBINATION
LV10417A (en) Placebo
DE9216064U1 (en) Cross bolt fitting